Cargando…
The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
Circulating cell-free DNA (cfDNA) are highly degraded DNA fragments shed into the bloodstream. Apoptosis is likely to be the main source of cfDNA due to the matching sizes of cfDNA and apoptotic DNA cleavage fragments. The study of cfDNA in liquid biopsies has served clinical research greatly. Genet...
Autores principales: | Martins-Ferreira, Ricardo, Leal, Bárbara Guerra, Costa, Paulo Pinho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987989/ https://www.ncbi.nlm.nih.gov/pubmed/35401115 http://dx.doi.org/10.3389/fncel.2022.852151 |
Ejemplares similares
-
Circulating cell-free DNA methylation mirrors alterations in cerebral patterns in epilepsy
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022) -
Mesial Temporal Lobe Epilepsy (MTLE) Drug-Refractoriness Is Associated With P2X7 Receptors Overexpression in the Human Hippocampus and Temporal Neocortex and May Be Predicted by Low Circulating Levels of miR-22
por: Guerra Leal, Bárbara, et al.
Publicado: (2022) -
The potential role of DNA methylation as preventive treatment target of epileptogenesis
por: Berger, Toni Christoph, et al.
Publicado: (2022) -
Homeostatic Plasticity in Epilepsy
por: Lignani, Gabriele, et al.
Publicado: (2020) -
Editorial: Epilepsy and Neurodevelopmental Diseases
por: Ruffolo, Gabriele, et al.
Publicado: (2020)